Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-11-001748
Filing Date
2011-01-06
Accepted
2011-01-06 19:11:52
Documents
1
Period of Report
2010-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1643
  Complete submission text file 0001140361-11-001748.txt   3377
Mailing Address 4620 CREEKSTONE DRIVE SUITE 200 DURHAM NC 27703
Business Address 4620 CREEKSTONE DRIVE SUITE 200 DURHAM NC 27703 919-484-8484
ADHEREX TECHNOLOGIES INC (Issuer) CIK: 0001211583 (see all company filings)

EIN.: 000000000
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 623 FIFTH AVENUE SUITE 2601 NEW YORK NY 10022
Business Address
Lieberman David B. (Reporting) CIK: 0001509172 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32295 | Film No.: 11515383